サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1326581

動物用バイオマーカーの世界市場規模調査＆予測、動物タイプ別、製品タイプ別、用途別、疾患タイプ別、地域別分析、2023-2030年

Global Veterinary Biomarkers Market Size Study & Forecast, by Animal Type, by Product Type, by Application, by Disease Type and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
動物用バイオマーカーの世界市場規模調査＆予測、動物タイプ別、製品タイプ別、用途別、疾患タイプ別、地域別分析、2023-2030年
出版日: 2023年07月28日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用バイオマーカー市場は、2022年におよそ7億9,000万米ドルと評価され、予測期間2023-2030年には12.61%以上の健全な成長率で成長すると予測されています。

動物用バイオマーカーとは、血液、尿、組織などの動物の生体サンプル中に存在する測定可能な指標や物質を指し、動物の病気や状態の検出、診断、モニタリング、予測に使用されます。これらのバイオマーカーには、タンパク質、酵素、ホルモン、遺伝子マーカー、代謝産物、または生理学的、病理学的、薬理学的プロセスに反応して特定の変化を示すその他の分子が含まれます。さらに、コンパニオンアニマルの人口増加と相まって、動物におけるがんや心血管疾患などの慢性疾患の発生率が上昇していることが、動物用バイオマーカーの需要を大きく牽引しています。

動物用バイオマーカー市場は、製品提供の拡大、動物医療への支出の増加、新興国におけるペット飼育の増加によって牽引されています。米国ペット用品協会の2023年報告書によると、米国ではペット産業の支出は2018年の905億米ドルから2022年には1,368億米ドルに増加し、2023年末には1,436億米ドルにさらに増加すると予測されています。同様に、2020年のFEDIAFによると、欧州では、ペット関連のサービスや製品への実質的な支出は、合計212億米ドルでした。さらに、動物用バイオマーカー市場の成長は、バイオマーカーポートフォリオを強化するために大手企業が行っている研究開発努力によって促進されています。さらに、ペットの飼育率が上昇していることも、市場成長のさらなる要因となっています。しかし、バイオマーカーの開発と商業化に関連する高コストと、標準化されたバイオマーカーアッセイの利用可能性が限られていることが、2023～2030年の予測期間を通じて市場の成長を阻害しています。

動物用バイオマーカーの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。コンパニオンアニマルの大幅な普及とペットケアへの多額の年間支出により、北米が2022年の市場を独占しました。免許を持ち訓練を受けた獣医師の存在感が各国で高まり、動物病院の数が増加していることも、マーケット成長の触媒となっています。アジア太平洋地域は予測期間中に最も急成長すると予想され、この成長は動物ヘルスケア支出の増加、主要市場における可処分所得の増加、獣医診療におけるバイオマーカーの認知度向上などの要因によるものです。正確でタイムリーな疾病診断に対する需要の高まりや、インドのような新興諸国におけるペットの人間化の動向は、この地域市場の拡大に寄与しているさらなる要因です。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 動物用バイオマーカーの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 動物用バイオマーカーの世界市場力学

  • 動物用バイオマーカー市場の影響分析（2020-2030年）
    • 市場促進要因
      • 動物における慢性疾患の発生率の増加
      • コンパニオンアニマルの人口増加
    • 市場の課題
      • 動物用バイオマーカー開発コストの高さ
      • 標準化されたバイオマーカーアッセイが限られていること
    • 市場機会
      • 大手企業による研究開発活動の増加
      • ペットの飼育率の増加

第4章 動物用バイオマーカーの世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 動物用バイオマーカーの世界市場：動物タイプ別

  • 市場スナップショット
  • 動物用バイオマーカーの世界市場：動物タイプ別、実績 - ポテンシャル分析
  • 動物用バイオマーカーの世界市場：動物タイプ別、推定・予測2020～2030年
  • 動物用バイオマーカー市場、サブセグメント分析
    • コンパニオンアニマル
    • 生産動物

第6章 動物用バイオマーカーの世界市場：製品タイプ別

  • 市場スナップショット
  • 動物用バイオマーカーの世界市場：製品タイプ別、実績 - ポテンシャル分析
  • 動物用バイオマーカーの世界市場：製品タイプ別、推定・予測2020～2030年
  • 動物用バイオマーカー市場：サブセグメント分析
    • バイオマーカー、キット、試薬
    • バイオマーカーリーダー

第7章 動物用バイオマーカーの世界市場：用途別

  • 市場スナップショット
  • 動物用バイオマーカーの世界市場：用途別、実績 - ポテンシャル分析
  • 動物用バイオマーカーの世界市場：用途別、推定・予測2020-2030年
  • 動物用バイオマーカー市場、サブセグメント分析
    • 疾病診断
    • 前臨床調査
    • その他

第8章 動物用バイオマーカーの世界市場：疾患タイプ別

  • 市場スナップショット
  • 動物用バイオマーカーの世界市場：疾患タイプ別、実績 - ポテンシャル分析
  • 動物用バイオマーカーの世界市場：疾患タイプ別、推定・予測2020-2030年
  • 動物用バイオマーカー市場、サブセグメント分析
    • 炎症性疾患および感染性疾患
    • 心血管疾患
    • 骨格筋疾患
    • 腫瘍
    • その他

第9章 動物用バイオマーカーの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 動物用バイオマーカー市場、地域別市場スナップショット
  • 北米
    • 米国
      • 動物タイプの推定・予測、2020～2030年
      • 製品タイプの推定・予測、2020～2030年
      • 用途の推定・予測、2020～2030年
      • 疾病タイプの推定・予測、2020-2030年
    • カナダ
  • 欧州の動物用バイオマーカー市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の動物用バイオマーカー市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの動物用バイオマーカー市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第10章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Zoetis Services LLC
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Virbac
    • Veterinary Biomarkers, Inc.
    • ACUVET BIOTECH
    • Merck & Co., Inc.
    • IDEXX Laboratories, Inc.
    • MI：RNA Diagnostics Ltd
    • Mercodia AB
    • Antech Diagnostics, Inc.
    • Vimian Group

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Veterinary Biomarkers Market, report scope
  • TABLE 2. Global Veterinary Biomarkers Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Veterinary Biomarkers Market estimates & forecasts by Animal Type 2020-2030 (USD Billion)
  • TABLE 4. Global Veterinary Biomarkers Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
  • TABLE 5. Global Veterinary Biomarkers Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 6. Global Veterinary Biomarkers Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
  • TABLE 7. Global Veterinary Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Veterinary Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Veterinary Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Veterinary Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Veterinary Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Veterinary Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Veterinary Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Veterinary Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Veterinary Biomarkers Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Veterinary Biomarkers Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. U.S. Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21. Canada Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. Canada Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24. UK Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. UK Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27. Germany Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. Germany Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30. France Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. France Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33. Italy Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Italy Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36. Spain Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. Spain Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39. RoE Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. RoE Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42. China Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. China Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45. India Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. India Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48. Japan Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. Japan Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51. South Korea Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. South Korea Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54. Australia Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. Australia Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60. Brazil Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Brazil Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63. Mexico Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. Mexico Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66. RoLA Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. RoLA Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. Saudi Arabia Veterinary Biomarkers Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 69. South Africa Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. RoMEA Veterinary Biomarkers Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Veterinary Biomarkers Market
  • TABLE 72. List of primary sources, used in the study of global Veterinary Biomarkers Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Veterinary Biomarkers Market, research methodology
  • FIG 2. Global Veterinary Biomarkers Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Veterinary Biomarkers Market, key trends 2022
  • FIG 5. Global Veterinary Biomarkers Market, growth prospects 2023-2030
  • FIG 6. Global Veterinary Biomarkers Market, porters 5 force model
  • FIG 7. Global Veterinary Biomarkers Market, pest analysis
  • FIG 8. Global Veterinary Biomarkers Market, value chain analysis
  • FIG 9. Global Veterinary Biomarkers Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Veterinary Biomarkers Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Veterinary Biomarkers Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Veterinary Biomarkers Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Veterinary Biomarkers Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Veterinary Biomarkers Market, regional snapshot 2020 & 2030
  • FIG 15. North America Veterinary Biomarkers Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Veterinary Biomarkers Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Veterinary Biomarkers Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Veterinary Biomarkers Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Veterinary Biomarkers Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Veterinary Biomarkers Market is valued at approximately USD 0.79 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 12.61% over the forecast period 2023-2030. Veterinary biomarkers refer to measurable indicators or substances present in animals' biological samples, such as blood, urine, or tissues, that is used to detect, diagnose, monitor, or predict veterinary diseases or conditions. These biomarkers include proteins, enzymes, hormones, genetic markers, metabolites, or other molecules that exhibit specific changes in response to physiological, pathological, or pharmacological processes. Additionally, the rising incidence of chronic diseases such as cancer and cardiovascular conditions in animals, coupled with the expanding population of companion animals, is a significant driver for the demand for veterinary biomarker.

The veterinary biomarkers market is driven by the expansion of product offerings, higher expenditure on animal healthcare, and increased pet adoption in emerging nations. the American Pet Products Association's 2023 report stated thatin the United States, the pet industry expenditure increased from USD 90.5 billion in 2018 to USD 136.8 billion in 2022, with a projected further increase to USD 143.6 billion by the end of 2023. Similarly, according to FEDIAF in 2020, in Europe, substantial spending on pet-related services and products, totaled for 21.2 billion. Moreover, growth in the veterinary biomarkers market is being fueled by R&D efforts undertaken by major companies to enhance their biomarker portfolios. Furthermore, the increasing rates of pet adoption are serving as additional factors that contribute to the market's growth. However, the high cost associated with biomarker development and commercialization and the limited availability of standardized biomarker assays stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Veterinary Biomarkers Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the significant adoption of companion animals and substantial annual expenditure on pet care. The increasing presence of licensed and trained veterinarians in countries, along with the growing number of veterinary clinics, serves as another catalyst for the market's growth. Asia Pacific is expected to fastest growing during the forecast period, this growth is attributed to factors such as increased animal healthcare expenditure, rising disposable income in key markets, and growing awareness of biomarkers in veterinary practices. The growing demand for accurate and timely disease diagnosis, as well as the trend of pet humanization in developing countries such as India, are the further factors that are contributing to the regional market's expansion.

Major market players included in this report are:

  • Zoetis Services LLC
  • Virbac
  • Veterinary Biomarkers, Inc.
  • ACUVET BIOTECH
  • Merck & Co., Inc.
  • IDEXX Laboratories, Inc.
  • MI:RNA Diagnostics Ltd
  • Mercodia AB
  • Antech Diagnostics, Inc.
  • Vimian Group

Recent Developments in the Market:

  • In June 2023, IDEXX Laboratories, Inc., a renowned innovator in pet healthcare, recently introduced the world's first veterinary diagnostic test designed specifically for detecting kidney injury in both cats and dogs.
  • In February 2022, VMRD, Inc., a leading developer and manufacturer of veterinary diagnostic test kits and reagents, recently expanded its molecular product line by introducing nucleic acid extraction kits for gene sequencing and gene expression studies in animals. This kit enables rapid and efficient preparation of highly pure viral nucleic acids from various sample types such as tissue homogenates, swabs, serum, and plasma.

Global Veterinary Biomarkers Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Animal Type, Product Type, Application, Disease Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Animal Type:

  • Companion Animals
  • Production Animals

By Product Type:

  • Biomarkers, Kits & Reagents
  • Biomarker Readers

By Application:

  • Disease Diagnostics
  • Preclinical Research
  • Others

By Disease Type:

  • Inflammatory & Infectious Diseases
  • Cardiovascular Diseases
  • Skeletal Muscle Diseases
  • Tumor
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Veterinary Biomarkers Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Veterinary Biomarkers Market, by Animal Type, 2020-2030 (USD Billion)
    • 1.2.3. Veterinary Biomarkers Market, by Product Type, 2020-2030 (USD Billion)
    • 1.2.4. Veterinary Biomarkers Market, by Application, 2020-2030 (USD Billion)
    • 1.2.5. Veterinary Biomarkers Market, by Disease Type, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Veterinary Biomarkers Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Veterinary Biomarkers Market Dynamics

  • 3.1. Veterinary Biomarkers Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of chronic diseases in animals
      • 3.1.1.2. Growing population of companion animals
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of veterinary biomarkers development
      • 3.1.2.2. Limited availability of standardized biomarker assays
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing R&D activities undertaken by major companies
      • 3.1.3.2. Increasing rates of pet adoption

Chapter 4. Global Veterinary Biomarkers Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Veterinary Biomarkers Market, by Animal Type

  • 5.1. Market Snapshot
  • 5.2. Global Veterinary Biomarkers Market by Animal Type, Performance - Potential Analysis
  • 5.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Animal Type 2020-2030 (USD Billion)
  • 5.4. Veterinary Biomarkers Market, Sub Segment Analysis
    • 5.4.1. Companion Animals
    • 5.4.2. Production Animals

Chapter 6. Global Veterinary Biomarkers Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Veterinary Biomarkers Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
  • 6.4. Veterinary Biomarkers Market, Sub Segment Analysis
    • 6.4.1. Biomarkers, Kits & Reagents
    • 6.4.2. Biomarker Readers

Chapter 7. Global Veterinary Biomarkers Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Veterinary Biomarkers Market by Application, Performance - Potential Analysis
  • 7.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4. Veterinary Biomarkers Market, Sub Segment Analysis
    • 7.4.1. Disease Diagnostics
    • 7.4.2. Preclinical Research
    • 7.4.3. Others

Chapter 8. Global Veterinary Biomarkers Market, by Disease Type

  • 8.1. Market Snapshot
  • 8.2. Global Veterinary Biomarkers Market by Disease Type, Performance - Potential Analysis
  • 8.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
  • 8.4. Veterinary Biomarkers Market, Sub Segment Analysis
    • 8.4.1. Inflammatory & Infectious Diseases
    • 8.4.2. Cardiovascular Diseases
    • 8.4.3. Skeletal Muscle Diseases
    • 8.4.4. Tumor
    • 8.4.5. Others

Chapter 9. Global Veterinary Biomarkers Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Veterinary Biomarkers Market, Regional Market Snapshot
  • 9.4. North America Veterinary Biomarkers Market
    • 9.4.1. U.S. Veterinary Biomarkers Market
      • 9.4.1.1. Animal Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Product Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. Disease Type breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Veterinary Biomarkers Market
  • 9.5. Europe Veterinary Biomarkers Market Snapshot
    • 9.5.1. U.K. Veterinary Biomarkers Market
    • 9.5.2. Germany Veterinary Biomarkers Market
    • 9.5.3. France Veterinary Biomarkers Market
    • 9.5.4. Spain Veterinary Biomarkers Market
    • 9.5.5. Italy Veterinary Biomarkers Market
    • 9.5.6. Rest of Europe Veterinary Biomarkers Market
  • 9.6. Asia-Pacific Veterinary Biomarkers Market Snapshot
    • 9.6.1. China Veterinary Biomarkers Market
    • 9.6.2. India Veterinary Biomarkers Market
    • 9.6.3. Japan Veterinary Biomarkers Market
    • 9.6.4. Australia Veterinary Biomarkers Market
    • 9.6.5. South Korea Veterinary Biomarkers Market
    • 9.6.6. Rest of Asia Pacific Veterinary Biomarkers Market
  • 9.7. Latin America Veterinary Biomarkers Market Snapshot
    • 9.7.1. Brazil Veterinary Biomarkers Market
    • 9.7.2. Mexico Veterinary Biomarkers Market
  • 9.8. Middle East & Africa Veterinary Biomarkers Market
    • 9.8.1. Saudi Arabia Veterinary Biomarkers Market
    • 9.8.2. South Africa Veterinary Biomarkers Market
    • 9.8.3. Rest of Middle East & Africa Veterinary Biomarkers Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Zoetis Services LLC
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Virbac
    • 10.3.3. Veterinary Biomarkers, Inc.
    • 10.3.4. ACUVET BIOTECH
    • 10.3.5. Merck & Co., Inc.
    • 10.3.6. IDEXX Laboratories, Inc.
    • 10.3.7. MI:RNA Diagnostics Ltd
    • 10.3.8. Mercodia AB
    • 10.3.9. Antech Diagnostics, Inc.
    • 10.3.10. Vimian Group

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption